Dr Daniel Schwartz
  • Home
  • Privacy
  • About Dr. Daniel Schwartz
  • Contact
  • Docs
Select Page
Reducing Prescription Drug Costs in Canada

Reducing Prescription Drug Costs in Canada

by Daniel Schwartz | Sep 25, 2023 | Guidance for Patients, PHSP

Access to Care Reducing the Cost of Pharmaceuticals in Canada Canada is well-known for its universal healthcare system, which provides all citizens and permanent residents with access to medically necessary hospital and physician services without direct charges at the...

Recent Thoughts

  • SGLT2 Inhibitors at Low GFR: Are We Drawing the Line in the Wrong Place?
  • PharmaCare in BC: Bridging the Gaps in Prescription Coverage
  • Reducing Prescription Drug Costs in Canada
  • Tips for Starting an SGLT2 Inhibitor
  • Ten Ways Health IT Could Improve Access to Physicians
  • Finerenone After RAAS and SGLT2 Inhibition: Is Triple Therapy Appropriate?
  • Most Impactful Clinical Trials for Slowing CKD Progression
  • How EMPA-KIDNEY Changed Clinical Care in CKD
  • Personalized Decision Support: From NNT to iNNT
  • Could SPRINT Change the Systolic Blood Pressure Target?

Recent Comments

    Contact

    100-200 Keary St
    New Westminster, BC  V3L 0A6

    (604) 516-7774

    Learn More

    LinkedIn

    RateMDs

    UBC

    Magic

    • SGLT2 Inhibitors at Low GFR: Are We Drawing the Line in the Wrong Place?
    • PharmaCare in BC: Bridging the Gaps in Prescription Coverage
    • Reducing Prescription Drug Costs in Canada
    • Tips for Starting an SGLT2 Inhibitor
    • Ten Ways Health IT Could Improve Access to Physicians